Centessa Pharmaceuticals PLC
CNTA
Company Profile
Business description
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Contact
1 Ashley Road
3rd Floor
Altrincham
CheshireWA14 2DT
GBRSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
98
Stocks News & Analysis
stocks
Oracle shares are up 87% in 2025. Is it a buy?
Oracle’s cloud database business is riding the AI wave.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,057.60 | 48.70 | -0.53% |
| CAC 40 | 7,830.16 | 41.86 | -0.53% |
| DAX 40 | 23,679.16 | 67.83 | 0.29% |
| Dow JONES (US) | 46,437.07 | 144.29 | 0.31% |
| FTSE 100 | 9,249.51 | 26.19 | 0.28% |
| HKSE | 26,518.65 | 359.53 | 1.37% |
| NASDAQ | 22,594.85 | 21.38 | 0.09% |
| Nikkei 225 | 45,630.31 | 136.65 | 0.30% |
| NZX 50 Index | 13,181.31 | 44.77 | 0.34% |
| S&P 500 | 6,666.28 | 9.36 | 0.14% |
| S&P/ASX 200 | 8,764.50 | 50.50 | -0.57% |
| SSE Composite Index | 3,853.64 | 31.81 | 0.83% |